A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

Completed

Plain-English translation of NCT02573259 on ClinicalTrials.gov ↗ · Source last updated December 2021 · How we translate trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(67 sites)

United States

Clinical Research Unit, Los Angeles, California

Ronald Reagan Medical Center, Department of Radiological Sciences, Los Angeles, California

Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles, California

UCLA Hematology & Oncology Clinic, Los Angeles, California

Santa Monica UCLA Hematology & Oncology Clinic, Santa Monica, California